Vertex Pharmaceuticals (VRTX) Property, Plant & Equipment (Net) Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.28% |
| Dec 31, 2025 | 9.66% |
| Sep 30, 2025 | 9.13% |
| Jun 30, 2025 | 12.88% |
| Mar 31, 2025 | 11.97% |
| Dec 31, 2024 | 10.51% |
| Sep 30, 2024 | 8.79% |
| Jun 30, 2024 | 10.43% |
| Mar 31, 2024 | 9.57% |
| Dec 31, 2023 | 7.38% |
| Sep 30, 2023 | 6.82% |
| Jun 30, 2023 | 6.59% |
| Mar 31, 2023 | 6.78% |
| Dec 31, 2022 | 7.02% |
| Sep 30, 2022 | 8.04% |
| Jun 30, 2022 | 8.25% |
| Mar 31, 2022 | 9.35% |
| Dec 31, 2021 | 9.39% |
| Sep 30, 2021 | 8.68% |
| Jun 30, 2021 | 8.14% |
| Mar 31, 2021 | 7.39% |
| Dec 31, 2020 | 6.56% |
| Sep 30, 2020 | 5.44% |
| Jun 30, 2020 | 0.42% |
| Mar 31, 2020 | 0.77% |
| Dec 31, 2019 | 0.80% |
| Sep 30, 2019 | 0.35% |
| Jun 30, 2019 | 0.03% |
| Mar 31, 2019 | 0.45% |
| Dec 31, 2018 | 3.10% |
| Sep 30, 2018 | 4.49% |
| Jun 30, 2018 | 7.00% |
| Mar 31, 2018 | 9.69% |
| Dec 31, 2017 | 12.73% |
| Sep 30, 2017 | 43.67% |
| Jun 30, 2017 | 22.11% |
| Mar 31, 2017 | 32.98% |
| Dec 31, 2016 | 39.29% |
| Sep 30, 2016 | 46.68% |
| Mar 31, 2016 | 57.66% |
| Dec 31, 2015 | 57.35% |
| Sep 30, 2015 | 60.94% |
| Jun 30, 2015 | 63.83% |
| Mar 31, 2015 | 64.90% |
| Dec 31, 2014 | 62.96% |